Stock Markets March 9, 2026

Adeia Shares Rise After Multi-Year Licensing Pact with AMD

Agreement grants AMD access to Adeia IP and settles outstanding litigation; financial terms remain undisclosed

By Leila Farooq ADEA AMD
Adeia Shares Rise After Multi-Year Licensing Pact with AMD
ADEA AMD

Adeia Inc. stock climbed 5.7% on Monday after the company announced a multi-year licensing agreement with Advanced Micro Devices that provides AMD access to Adeia's semiconductor intellectual property portfolio and resolves all outstanding litigation between the two firms. Adeia did not disclose financial terms. The deal highlights Adeia's portfolio in hybrid bonding, packaging and processing technologies and its role licensing technology to semiconductor firms globally.

Key Points

  • Adeia shares rose 5.7% on Monday after announcing a multi-year licensing agreement with Advanced Micro Devices.
  • The agreement gives AMD access to Adeia's semiconductor IP portfolio and resolves all outstanding litigation between the two companies.
  • Adeia's IP covers hybrid bonding, semiconductor packaging and semiconductor processing technologies; the company licenses its technology globally and has developed innovations over 30 years.

Adeia Inc. (NASDAQ:ADEA) shares rose 5.7% on Monday following the announcement of a multi-year licensing agreement with Advanced Micro Devices. Under the agreement, AMD will obtain access to Adeia's semiconductor intellectual property portfolio, and the arrangement also resolves all outstanding litigation between the two companies. Adeia did not disclose the financial terms of the deal.

The agreement covers Adeia's intellectual property across several areas of semiconductor technology. Adeia's portfolio includes IP related to hybrid bonding, semiconductor packaging and semiconductor processing technologies. The company said it has developed semiconductor innovations over the past 30 years and licenses its technology to semiconductor companies around the world.

"We are pleased to reach this agreement with AMD, a global leader in high-performance computing and advanced semiconductor solutions," Paul E. Davis, chief executive officer of Adeia, commented. "Resolving our disputes allows both companies to move forward and creates an opportunity for exploring future collaborations on advanced semiconductor technologies."

Adeia was described in its announcement as a technology company that develops solutions for the semiconductor and media industries. The licensing arrangement grants AMD access to Adeia's comprehensive semiconductor IP portfolio, though the announcement did not break out licensing fees, royalty rates or other monetary details.

The settlement of litigation between the two companies was stated explicitly in the announcement. The resolution removes the outstanding legal disputes as a current obstacle to cooperation, while the licensing agreement establishes a formal channel for AMD to use Adeia's IP.


Sectors impacted

  • Semiconductor industry
  • Technology and media sectors

This report presents the facts released by Adeia and reflects the information available in the company announcement. The financial terms of the arrangement remain unspecified in the public disclosure.

Risks

  • Financial terms of the licensing arrangement were not disclosed, leaving the monetary impact on either company unspecified - impacts investors and the semiconductor sector.
  • The announcement does not specify operational details or scope of the license, creating uncertainty about the extent of technology access and commercial arrangements - relevant to semiconductor partners and customers.
  • While litigation has been resolved according to the announcement, the long-term commercial relationship and potential future collaborations are described as opportunities rather than confirmed plans, leaving future outcomes uncertain - affects technology and media sectors.

More from Stock Markets

WuXi AppTec Shares Surge as Annual Profit More Than Doubles Mar 24, 2026 U.S. Stocks Showing Relative Resilience Amid Iran Conflict, but Risks Remain Mar 24, 2026 European New Car Registrations Tick Up in February as EV Momentum Continues Mar 24, 2026 Keymed Biosciences Set to Receive Up to $320 Million After Gilead Acquires Ouro Medicines Mar 24, 2026 Iran Fires Multiple Missile Waves at Israel as Negotiation Claims Are Disputed Mar 24, 2026